tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Jason Mccarthy, 191 are a BUY (83.77%), 34 are a HOLD (14.91%), 3 are a SELL (1.32%).
Analyst Jason Mccarthy, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 36.96% that have a potential upside of 53.23% achieved within 204 days.
Jason Mccarthy’s has documented 449 price targets and ratings displayed on 69 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on BNGO, Bionano Genomics at 20-May-2025.
Analyst best performing recommendations are on ONTX (ONCONOVA THERAPEUTICS).
The best stock recommendation documented was for CAPR (CAPRICOR THERAPEUTICS) at 9/17/2024. The price target of $12 was fulfilled within 13 days with a profit of $6.92 (136.22%) receiving and performance score of 104.78.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$20
$13.58 (211.53%)
$15
28 days ago
(30-Apr-2025)
0/7 (0%)
$13.44 (204.88%)
Buy
$18
$11.58 (180.37%)
$18
6 months 29 days ago
(29-Oct-2024)
1/5 (20%)
$11.43 (173.97%)
61
Hold
$6
$-0.42 (-6.54%)
$25
2 years 6 months 14 days ago
(14-Nov-2022)
1/2 (50%)
$1.85 (44.58%)
452
Buy
$75
$70.79 (1681.47%)
$50
4 years 6 months 17 days ago
(11-Nov-2020)
2/3 (66.67%)
$45.92 (117.11%)
101
Buy
$22
5 years 20 days ago
(08-May-2020)
1/3 (33.33%)
$-59.25 (-72.92%)
820
Which stock is Jason Mccarthy is most bullish on?
Which stock is Jason Mccarthy is most reserved on?
What Year was the first public recommendation made by Jason Mccarthy?
